Abstract
The cytochrome P450 (P450)-dependent conversion of phenytoin (PHT) to p-hydroxy phenytoin (pHPPH), and tolbutamide (TLB) to 4-hydroxy tolbutamide (hydroxy-TLB), in human liver microsomes was studied in the presence of increasing concentrations (0–4%) of bovine serum albumin (BSA). Therefore, the free fraction (fu) of PHT and TLB varied. Whereas the fu of PHT (5 μM) decreased, an increase (3-fold), rather than a decrease in the pHPPH formation rate was observed when BSA (<1%) was present. The stimulation was attributed to a significant decrease in apparentKm. The change, however, was diminished as the BSA concentration reached 4% (PHTfu = 0.2), in which the reaction velocity remained the same as that measured in the absence of BSA. Therefore, unchanged Km (16.2 ± 0.7 μM) and Vmax (9.4 ± 0.2 pmol/min/mg of protein) values were determined based on total PHT concentrations, whereas correction for fu led to an unboundKm (Kmu) of ∼3.2 μM. Similarly, the metabolism of TLB (50 μM) was enhanced (∼2-fold) in the presence of 0.25% BSA but remained only 35% of the control activity (no BSA) at 1% BSA. However, the remaining activity was higher (3-fold) than that determined with an equivalent free concentration of TLB (4 μM) calculated according to itsfu (0.08). The difference became less significant when BSA concentration was 4% (fu < 0.02). Collectively, the results suggest a 2-fold effect of BSA on PHT and TLB hydroxylation: first, facilitation of the reactions via a decrease inKm; second, a decrease infu leading to a drop in reaction rate. For a given P450 reaction, therefore, the effect of BSA may depend upon enzyme affinity, catalytic capacity, and the extent of protein binding.
Footnotes
- Abbreviations used are::
- BSA
- bovine serum albumin
- PHT
- phenytoin
- OH-TLB
- 4-hydroxyl tolbutamide
- pHPPH
- p-hydroxy phenytoin
- MPHT
- (±)-5-(4-methylphenyl)-5-phenylhydantion
- CPPM
- chlorpropamide
- HLM
- human liver microsomes
- LC-MS/MS
- liquid chromatography/tandem mass spectrometry
- fu
- mean unbound fraction of substrate
- Received December 28, 2001.
- Accepted February 21, 2002.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|